Implantable controlled release devices for BMP-7 delivery and suppression of glioblastoma initiating cells

Biomaterials

Volumn 35, Issue 9, 2014, Pages 2859-2867

  Reguera Nuñez, Elaine ^a,b   Roca, Carlota ^a   Hardy, Eugenio ^b   de la Fuente, Maria ^a   Csaba, Noemi ^a   Garcia Fuentes, Marcos ^a  

^a Universidad de Santiago de Compostela ^*  (Spain)

^b UNIVERSITY OF HAVANA   (Cuba)

Author keywords

Bone morphogenetic protein; Cancer initiating cells; Controlled release; Glioblastoma; Microspheres; PLGA

Indexed keywords

BONE; CELL CULTURE; DISEASES; MICROSPHERES; PROTEINS; TUMORS;

BIODEGRADABLE POLYESTERS; BONE MORPHOGENETIC PROTEIN-7; BONE MORPHOGENETIC PROTEINS; CELL CULTURE MODELS; CONTROLLED RELEASE; CONTROLLED RELEASE DEVICES; GLIOBLASTOMAS; PLGA;

CELLS;

CHYMOTRYPSINOGEN; HEPARIN; MICROSPHERE; OSTEOGENIC PROTEIN 1;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CELL PROLIFERATION; CONTROLLED RELEASE DEVICE; CONTROLLED STUDY; DRUG DELIVERY DEVICE; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG EFFICACY; DRUG FORMULATION; DRUG MECHANISM; ENCAPSULATION; GLIOBLASTOMA; GLIOBLASTOMA INITIATING CELL; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; PARTICLE SIZE; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SUSTAINED DRUG RELEASE; TUMOR CELL; TUMOR GROWTH; TUMOR RECURRENCE;

BONE MORPHOGENETIC PROTEIN; CANCER INITIATING CELLS; CONTROLLED RELEASE; GLIOBLASTOMA; MICROSPHERES; PLGA;

ANTINEOPLASTIC AGENTS; BONE MORPHOGENETIC PROTEIN 7; BROMODEOXYURIDINE; CELL CYCLE; CELL LINE, TUMOR; DELAYED-ACTION PREPARATIONS; GLIOBLASTOMA; HUMANS; MICROSPHERES; NANOPARTICLES; NEOPLASTIC STEM CELLS; POLYMERS; PROSTHESES AND IMPLANTS; SPHEROIDS, CELLULAR;

EID: 84894963068     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.12.001     Document Type: Article

References (38)

1. Pistollato F., Rampazzo E., Abbadi S., Puppa A.D., Scienza R., D'Avella D., et al. Molecular mechanisms of HIF-1a modulation induced by oxygen tension and BMP2 in glioblastoma derived cells. PLoS ONE 2009, 4:e6206. 15p.
2. Surawicz T.S., Davis F., Freels S., Laws E.R., Menck H.R. Brain tumor survival: results from de National Cancer Data Base. J Neuro-Oncol 1998, 40:151-160.
3. Wang Y., Jiang T. Understanding high grade glioma: molecular mechanism, therapy and comprehensive management. Cancer Lett 2013, 331:139-146.
4. Chen J., Li Y., Yu T.-S., McKay R.M., Burns D.K., Kernie S.G., et al. A restricted cell population propagates glioblastoma growth after chemotherapy. Nature 2012, 488:522-526.
5. Dirks P.B. Stem cells and brain tumours. Nature 2006, 444:687-688.
6. Galli R., Binda E., Orfanelli U., Cipelletti B., Gritti A., Vitis S.D., et al. Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res 2004, 64:7011-7021.
7. Singh S.K., Hawkins C., Clarke I.D., Squire J.A., Bayani J., Hide T., et al. Identification of human brain tumour initiating cells. Nature 2004, 432:396-401.
8. Winquist R.J., Boucher D.M., Wood M., Furey B.F. Targeting cancer stem cells for more effective therapies: taking out cancer's locomotive engine. Biochem Pharmacol 2009, 78:326-334.
9. Pardridge W.M. Blood-brain barrier delivery. Drug Discov Today 2007, 12:54-61.
10. Zhou Y., Tozzi F., Chen J., Fan F., Xia L., Wang J., et al. Intracellular ATP levels are a pivotal determinant of chemoresistance in colon cancer cells. Cancer Res 2012, 72:304-314.
11. Chirasani S.R., Sternjak A., Wend P., Momma S., Campos B., Herrmann I.M., et al. Bone morphogenetic protein-7 release from endogenous neural precursor cells suppresses the tumourigenicity of stem-like glioblastoma cells. Brain 2010, 133:1961-1972.
12. Klose A., Waerzeggers Y., Monfared P., Vukicevic S., Kaijzel E.L., Winkeler A., et al. Imaging bone morphogenetic protein 7 induced cell cycle arrest in experimental gliomas. Neoplasia 2011, 13:276-285.
13. Nakano I., Saigusa K., Kornblum H.I. BMPing off glioma stem cells. Cancer Cell 2008, 13:3-4.
14. Piccirillo S.G.M., Reynolds B.A., Zanetti N., Lamorte G., Binda E., Broggi G., et al. Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells. Nature 2006, 444:761-765.
15. Vaccari J.Pd.R., Marcillo A., Nonner D., Dietrich W.D., Keane R.W. Neuroprotective effects of bone morphogenetic protein 7 (BMP-7) treatment after spinal cord injury. Neurosci Lett 2009, 465:226-229.
16. Menei P., Venier M.C., Gamelin E., Saint-André J.P., Hayek G., Jadaud E., et al. Local and sustained delivery of 5-fluorouracil from biodegradable microspheres for the radiosensitization of glioblastoma. Cancer Res 1999, 86:325-330.
17. Zhu G., Mallery S.R., Schwendeman S.P. Stabilization of proteins encapsulated in injectable poly(lactide-co-glycolide). Nat Biotechnol 2000, 18:52-57.
18. Wang N.X., von Recum H.A. Affinity-based drug delivery. Macromol Biosci 2011, 11:321-332.
19. Csaba N., Caamaño P., Sánchez A., Domínguez F., Alonso M.J. PLGA: poloxamer and PLGA: poloxamine blend nanoparticles: new carriers for gene delivery. Biomacromolecules 2005, 6:271-278.
20. Csaba N., González L., Sánchez A., Alonso M.J. Design and characterisation of new nanoparticle polymer blends for drug delivery. J Biomater Sci-Polym Ed 2004, 15:1137-1151.
21. Parajó Y., d'Angelo I., Horváth A., Vantus T., György K., Welle A., et al. PLGA:poloxamer blend micro- and nanoparticles as controlled release systems for synthetic proangiogenic factors. Eur J Pharm Sci 2010, 41:644-649.
22. Tobío M., Nolley J., Guo Y., McIver J., Alonso M.J. A novel system based on a poloxamer/PLGA blends as a tetanus toxoid delivery vehicle. Pharm Res 1999, 16:682-688.
23. Sah H. A new strategy to determine the actual protein content of poly(lactide-co-glycolide) microspheres. J Pharm Sci 1997, 86:1315-1318.
24. Freitas S., Merkle H.P., Gander B. Microencapsulation by solvent extraction/evaporation: reviewing the state of the art of microsphere preparation process technology. J Control Release 2005, 102:313-332.
25. Santander-Ortega M.J., Csaba N., González L., Bastos-González D., Ortega-Vinuesa J.L., Alonso M.J. Protein-loaded PLGA-PEO blend nanoparticles: encapsulation, release and degradation characteristics. Colloid Polym Sci 2010, 288:141-150.
26. Reynolds B.A., Weiss S. Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science 1992, 255:1707-1710.
27. Visvader J.E., Lindeman G.J. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nature 2008, 8:755-768.
28. Azvolinsky A. Companies hope for rare win with cancer stem cell therapies. Nat Med 2012, 18:474.
29. Lee J., Son M.J., Woolard K., Donin N.M., Li A., Cheng C.H., et al. Epigenetic-mediated dysfunction of the bone morphogenetic protein pathway inhibits differentiation of glioblastoma-initiating cells. Cancer Cell 2008, 13:69-80.
30. Lee K., Silva E.A., Mooney D.J. Growth factor delivery-based tissue engineering:general approaches and a review of recent developments. J R Soc Interface 2011, 8:153-170.
31. Chen W., He J., Olson J.J., Lu D.R. Direct intracerebral delivery of carboplatin from PLGA microspheres against experimental malignant glioma in rats. Drug Deliv 1998, 5:101-110.
32. Menei P., Daniel V., Montero-Menei C., Brouillard M., Pouplard-Barthelaix A., Benoit J.P. Biodegradation and brain tissue reaction to poly(D,L-lactide-co-glycolide) microspheres. Biomaterials 1993, 14:470-478.
33. Ranganath S.H., Fu Y., Arifin D.Y., Kee I., Zheng L., Lee H.-S., et al. The use of submicron/nanoscale PLGA implants to deliver paclitaxel with enhanced pharmacokinetics and therapeutic efficacy in intracranial glioblastoma in mice. Biomaterials 2010, 31:5199-5207.
34. Shen H., Hu X., Yang F., Bei J., Wang S. An injectable scaffold: rhBMP-2-loaded poly(lactide-co-glycolide)/hydroxyapatite composite microspheres. Acta Biomater 2010, 6:455-465.
35. d'Angelo I., Garcia-Fuentes M., Parajó Y., Welle A., Vántus T., Horváth A., et al. Nanoparticles based on PLGA: poloxamer blends for the delivery of proangiogenic growth factors. Mol Pharm 2010, 7:1724-1733.
36. Jensen J.B., Parmar M. Strengths and limitations of neurosphere culture system. Mol Neurobiol 2006, 34:153-161.
37. Biondi M., Ungaro F., Quaglia F., Netti P.A. Controlled drug delivery in tissue engineering. Adv Drug Deliv Rev 2008, 60:229-242.
38. ® block copolymers as novel polymer therapeutics for drug and gene delivery. J Control Release 2002, 82:189-212.